A Clinicopathological Analysis of Membranous Nephropathy and Its Correlation With the Immunohistochemical Expression of Phospholipase A2 Receptor (PLA2R) in Renal Biopsies in a Tertiary Care Center. [PDF]
K H +5 more
europepmc +1 more source
Fibrinogen-albumin ratio predicts treatment response in phospholipase A2 receptor-associated membranous nephropathy with nephrotic syndrome. [PDF]
Duan S +11 more
europepmc +1 more source
Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy. [PDF]
Hu X +17 more
europepmc +1 more source
Obinutuzumab in Difficult to Treat Phospholipase A2 Receptor Positive Membranous Nephropathy: Our Experience at a Tertiary Care Center in North India. [PDF]
Jha VK, Panda SK, Rai SK, Srivastava AK.
europepmc +1 more source
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy. [PDF]
Rovin BH +15 more
europepmc +1 more source
Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: New concepts
Mohammad-Reza Ardalan, Hamid Nasri
doaj
Diagnostic value of renal biopsy in anti-phospholipase A2 receptor antibody-positive patients with proteinuria in China. [PDF]
Lu S +5 more
europepmc +1 more source
A comparison of chemiluminescent immunoassay and enzyme-linked immunosorbent assay for detecting phospholipase A2 receptor antibody in primary membranous nephropathy. [PDF]
Ma X +8 more
europepmc +1 more source
Obinutuzumab for treatment of membranous nephropathy in patients positive and negative for the phospholipase A<sub>2</sub> receptor antibody: case reports. [PDF]
Wang J, Wu W, Wu H.
europepmc +1 more source

